Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha lipoic acid supplementation in patients with psoriasis
IRCT20230123057193N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alpha-lipoic acid in psoriasis, sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in serum disease-related factors, Change in serum disease enzymes and 2 more. Started Apr 2024; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
psoriasis
Beyond the preview
Go deeper on IRCT20230123057193N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230123057193N3.